Search Results - "Komsalova, Liliya Yankova"

Predictive values of inflammatory back pain, positive HLA B27 antigen and acute and chronic magnetic resonance changes in early diagnosis of Spondyloarthritis. A study of 133 patients by Komsalova, Liliya Yankova, Martínez Salinas, Mª Pilar, Jiménez, José Fermín Gómez

“…To analyse the predictive values of inflammatory back pain (IBP), positive HLA B27 antigen, increased C-reactive protein (CRP), Spondyloarthritis (SpA)…”
Get full text

Corrigendum: Real-world experience with secukinumab in the entire axial spondyloarthritis spectrum by Sivera, Francisca, Núñez-Monje, Victoria, Campos-Fernández, Cristina, Balaguer-Trull, Isabel, Robustillo-Villarino, Montserrat, Aguilar-Zamora, Marta, Garijo-Bufort, Marta, López-Gómez, Juan Miguel, Peña-González, Carolina, de la Morena, Isabel, Bedoya-Sanchís, Diego, Yankova-Komsalova, Liliya, Conesa-Mateos, Arantxa, Martínez-Cristóbal, Anna, Navarro-Blasco, Francisco Javier, Senabre-Gallego, José Miguel, Alegre-Sancho, Juan José

“…[This corrects the article DOI: 10.3389/fmed.2023.1156557.]…”
Get full text

Real-world effectiveness and persistence of secukinumab in the treatment of patients with psoriatic arthritis by Alegre-Sancho, Juan José, Núñez-Monje, Victoria, Campos-Fernández, Cristina, Balaguer-Trull, Isabel, Robustillo-Villarino, Montserrat, Aguilar-Zamora, Marta, Garijo-Bufort, Marta, Pedraz-Penalva, Teresa, Peña-González, Carolina, de la Morena, Isabel, Bedoya-Sanchís, Diego, Yankova-Komsalova, Liliya, Conesa-Mateos, Arantxa, Martinez-Cristóbal, Anna, Navarro-Blasco, Francisco Javier, Senabre-Gallego, Jose Miguel, Sivera, Francisca

“…Psoriatic arthritis (PsA) is a complex and heterogeneous inflammatory disease. Secukinumab, a biologic disease-modifying antirheumatic drug (bDMARD), has…”
Get full text

Real-world experience with secukinumab in the entire axial spondyloarthritis spectrum by Sivera, Francisca, Núñez-Monje, Victoria, Campos-Fernández, Cristina, Balaguer-Trull, Isabel, Robustillo-Villarino, Montserrat, Aguilar-Zamora, Marta, Garijo-Bufort, Marta, López-Gómez, Juan Miguel, Peña-González, Carolina, de la Morena, Isabel, Bedoya-Sanchís, Diego, Yankova-Komsalova, Liliya, Conesa-Mateos, Arantxa, Martínez-Cristóbal, Anna, Navarro-Blasco, Francisco Javier, Senabre-Gallego, José Miguel, Alegre-Sancho, Juan José

“…Secukinumab is a biologic disease-modifying antirheumatic drug (bDMARD) that has demonstrated efficacy in the treatment of axial spondyloarthritis (axSpA,…”
Get full text

Clinical outcomes of switching to adalimumab biosimilar (MSB11022) in patients with rheumatoid arthritis: RESTART Spanish Registry by García-Miguel, Javier, Yankova Komsalova, Liliya, Mata Arnaiz, Cristina, Alegre-Sancho, Juan José, González Polo, Javier, Torrente-Segarra, Vicenç, Tornero Molina, Jesús, Navarro Angeles, Vanessa Andrea, Caramés, Cristina, Cristóbal, Ion

“…MSB11022 is a biosimilar of adalimumab that has been shown comparable bioequivalence, safety, tolerability, and immunogenicity profiles to the reference…”
Get full text